文献速递神经肿瘤

分泌型簇集蛋白通过调控肿瘤细胞与巨噬细胞抑制人脑膜瘤肿瘤发生

Secreted clusterin inhibits tumorigenesis by modulating tumor cells and macrophages in human meningioma.
PubMed 文献 · Neuro Oncol · 2024-01-01

研究对涵盖正常脑膜、良性与高级别原位肿瘤及肺转移的18例样本行单细胞转录组分析,并在小鼠与临床队列中验证,发现簇集蛋白(CLU)经其分泌型诱导线粒体损伤并触发1型干扰素通路,抑制脑膜瘤发生与恶性进展;TNFα可增强该抑制效应,胞内外CLU过表达促进巨噬细胞向M1极化及TNFα产生,增强肿瘤杀伤与吞噬。

要点

  • CLU经分泌型诱导线粒体损伤并触发1型干扰素通路,抑制脑膜瘤发生与恶性进展。
  • TNFα因也诱导1型干扰素通路而增强CLU的抑制效应。
  • 胞内外CLU过表达促进巨噬细胞向M1极化及TNFα产生,增强肿瘤杀伤与吞噬。

核心结论

  • CLU可能通过同步调控肿瘤细胞及其微环境成为脑膜瘤恶性的关键刹车,为脑膜瘤恶性机制提供全面认识并提示潜在治疗策略。

研究设计与样本

  • 对涵盖正常脑膜、良性与高级别原位肿瘤及肺转移的18例样本行单细胞转录组分析以刻画恶性进程转录组特征,并在动物模型与细胞水平对候选抑癌基因及分子机制进行功能验证。

主要发现

  • 小鼠与临床队列的综合分析与验证表明,CLU经其分泌型诱导线粒体损伤并触发1型干扰素通路,对脑膜瘤肿瘤发生与恶性具有抑制功能。
  • TNFα因也诱导1型干扰素通路而增强CLU的抑制效应。
  • 胞内与胞外CLU过表达均增强巨噬细胞向M1表型极化及TNFα产生,从而促进肿瘤杀伤与吞噬。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meningioma is the most common primary intracranial tumor with a high frequency of postoperative recurrence, yet the biology of the meningioma malignancy process is still obscure. METHODS: To identify potential therapeutic targets and tumor suppressors, we performed single-cell transcriptome analysis through meningioma malignancy, which included 18 samples spanning normal meninges, benign and high-grade in situ tumors, and lung metastases, for extensive transcriptome characterization. Tumor suppressor candidate gene and molecular mechanism were functionally validated at the animal model and cellular levels. RESULTS: Comprehensive analysis and validation in mice and clinical cohorts indicated clusterin (CLU) had suppressive function for meningioma tumorigenesis and malignancy by inducing mitochondria damage and triggering type 1 interferon pathway dependent on its secreted isoform, and the inhibition effect was enhanced by TNFα as TNFα also induced type 1 interferon pathway. Meanwhile, both intra- and extracellular CLU overexpression enhanced macrophage polarization towards M1 phenotype and TNFα production, thus promoting tumor killing and phagocytosis. CONCLUSIONS: CLU might be a key brake of meningioma malignance by synchronously modulating tumor cells and their microenvironment. Our work provides comprehensive insights into meningioma malignancy and a potential therapeutic strategy.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Ke C, Huang B, Xiang J, et al. Secreted clusterin inhibits tumorigenesis by modulating tumor cells and macrophages in human meningioma. Neuro Oncol. 2024. PMID: 38416702. doi:10.1093/neuonc/noae034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。